Apolipoprotein A-IV and its relation to cardiovascular endpoints and all-cause mortality in patients on hemodialysis – the 4D Study

Barbara Kollerits, Vera Krane, Christiane Drechsler, Claudia Lamina, Eberhard Ritz, Christoph Wanner & Florian Kronenberg
Background: Apolipoprotein A-IV (apoA-IV) is a 46 kDa glycoprotein almost exclusively produced in intestinal enterocytes. In vitro studies suggest a role for apoA-IV in reverse cholesterol transport. ApoA-IV has been linked to hepatic lipid metabolism, physiological control of food intake, body weight[for full text, please go to the a.m. URL]